Shares of Integrated BioPharma, Inc. (OTCMKTS:INBP – Get Free Report) traded down 5.4% during mid-day trading on Monday . The company traded as low as $0.27 and last traded at $0.31. 2,800 shares changed hands during trading, a decline of 86% from the average session volume of 20,310 shares. The stock had previously closed at $0.33.
Integrated BioPharma Price Performance
The firm has a market capitalization of $9.33 million, a P/E ratio of 10.27 and a beta of 0.62. The business has a 50 day moving average price of $0.34 and a 200 day moving average price of $0.29.
About Integrated BioPharma
Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.
Further Reading
- Five stocks we like better than Integrated BioPharma
- Top Biotech Stocks: Exploring Innovation Opportunities
- Finding Hidden Gems: Unconventional Penny Stock Investing
- Growth Stocks: What They Are, What They Are Not
- Price Targets on NVIDIA Rise in Front of Earnings
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
